Amphotericin B (AmB) is the drug of choice to treat systemic fungal infection. AmB is available as parenteral infusions given over a long period of time to hospitalized patients. Our goal is to develop a novel oral formulation to enhance AmB low absorption and decrease the nephrotoxicity associated with its intravenous administration. AmB will be […]
Read More